Teva ProAir Petition Says Generics Need To Match Integrated Dose Counter
This article was originally published in The Pink Sheet Daily
Executive Summary
Teva argues for inhaler design requirements that go beyond issues discussed in the draft bioequivalence guidance for albuterol sulfate metered inhalers that FDA released in April.